浙江高跖医药科技股份有限公司

Zhejiang Gaozhi Pharmaceutical Technology is a China-based Contract Research Organization (CRO) and Site Management Organization (SMO) that provides comprehensive clinical research services. Founded in 2015 and headquartered in Hangzhou, the company specializes in clinical trial management, regulatory affairs, data management, and statistical analysis for both the pharmaceutical and medical device sectors. Gaozhi Pharma supports clients through all phases of clinical development, ensuring compliance with NMPA regulations and international standards. The company is publicly listed on the National Equities Exchange and Quotations (NEEQ) in China, positioning itself as a key service provider in the domestic drug development ecosystem.